Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy

Cartesian Therapeutics doses first patient in phase 2 clinical trial of Descartes─08 to treat systematic lupus erythematosus

pharmabiz.com - 04/Jul 00:00

Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...

EG 427 receives US FDA clearance to initiate phase 1b/2a study of gene therapy, EG110A to treat NDO in spinal cord injury patients

pharmabiz.com - 26/Jun 00:00

EG 427, a biotechnology company leading the development of pinpoint DNA medicines for prevalent diseases in neurology based on its unique...

First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus

drugs.com - 03/Jul 04:07

GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell...

Stem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes

drugs.com - 25/Jun 10:06

TUESDAY, June 25, 2024 -- An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients,...

ASTRO issues clinical guideline on radiation therapy for patients with HPV-related throat cancer

oncologynews.com.au - 25/Jun 13:46

The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...

Waste-to-hydrogen startup awarded $50,000 MVP grant

aumanufacturing.com.au - 01/Jul 23:34

EM Energy, a startup commercialising a method of making green hydrogen from organic waste, has been awarded a $50,000 MVP grant from the NSW...

Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials

financialpost.com - 21/Jun 21:02

ALS Trial Navigator Offers People Living with ALS an Easy Way to Search Eligible Research Studies REDLANDS, Calif. — The ALS Therapy Development...

EMA initiates review of Roche's Elevidys MAA for treatment of Duchenne muscular dystrophy

pharmabiz.com - 25/Jun 00:00

Roche announced that the European Medicines Agency (EMA) has validated and initiated review of the marketing authorisation application (MAA) for...

Charles River (CRL) Inks CDMO Deal With Gates Institutes

zacks.com - 26/Jun 11:46

Charles River (CRL) signs a lentiviral vector contract development and manufacturing organization agreement with Gates Institute to help develop...

Somali American Social Service Association awarded $1 million grant

hiiraan.com - 22/Jun 07:23

ROCHESTER, Minn.- The Minnesota Department of Employment and Economic Development is awarding $12 million in workforce development grants to...

Rubriques :